UM

Browse/Search Results:  1-10 of 13 Help

Selected(0)Clear Items/Page:    Sort:
Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape Journal article
Psychological Medicine, 2020
Authors:  Kinoshita,Shotaro;  Cortright,Kelley;  Crawford,Allison;  Mizuno,Yuya;  Yoshida,Kazunari;  Hilty,Donald;  Guinart,Daniel;  Torous,John;  Correll,Christoph U.;  Castle,David J.;  Rocha,Deyvis;  Yang,Yuan;  Xiang,Yu Tao;  Kølbæk,Pernille;  Dines,David;  Elshami,Mohammad;  Jain,Prakhar;  Kallivayalil,Roy;  Solmi,Marco;  Favaro,Angela;  Veronese,Nicola;  Seedat,Soraya;  Shin,Sangho;  De Pablo,Gonzalo Salazar;  Chang,Chun Hung;  Su,Kuan Pin;  Karas,Hakan;  Kane,John M.;  Yellowlees,Peter;  Kishimoto,Taishiro
Favorite |  | TC[WOS]:0 TC[Scopus]:13 | Submit date:2021/03/02
Covid-19  Government Regulation  Health Insurance Reimbursement  Telemedicine  Telepsychiatry  
An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes Journal article
JOURNAL OF PSYCHOPHARMACOLOGY, 2019,Volume: 33,Issue: 10,Page: 1227-1236
Authors:  Zhang Cheng;  Yanbo Yuan;  Xue Han;  Shangli Cai;  Fude Yang;  Zheng Lu;  Chuanyue Wang;  Hong Deng;  Jingping Zhao;  Yutao Xiang;  Christoph U Correll;  Xin Yu
Favorite |  | TC[WOS]:5 TC[Scopus]:8 | Submit date:2020/05/26
First-episode  Schizophrenia  Antipsychotic  Efficacy  Safety  
Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor Journal article
CNS Spectrums, 2019,Volume: 24,Issue: 3,Page: 313-321
Authors:  Xiao,Le;  Correll,Christoph U.;  Feng,Lei;  Xiang,Yu Tao;  Feng,Yuan;  Hu,Chang Qing;  Li,Rena;  Wang,Gang
Favorite |  | TC[WOS]:2 TC[Scopus]:4 | Submit date:2021/03/02
brain-derived neurotrophic factor  Major depressive disorder  mediator  moderator  rhythmic magnetic stimulation  
Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial Journal article
Psychiatry Research, 2019,Volume: 273,Page: 631-640
Authors:  Cheng Zhang;  Yuan Yanbo;  Han Xue;  Yang Lei;  Zeng Xin;  Yang Fude;  Lu Zheng;  Wang Chuanyue;  Deng Hong;  Zhao Jingping;  Xiang Yu-Tao;  Christoph U. Correll;  Yu Xin
Favorite |  | TC[WOS]:4 TC[Scopus]:3 | Submit date:2020/09/25
First-episode  Antipsychotic  Discontinuation  Predictors  Schizophrenia  
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial Journal article
JOURNAL OF CLINICAL PSYCHIATRY, 2017,Volume: 78,Issue: 9,Page: E1158-+
Authors:  Xiao, Le;  Ganocy, Stephen J.;  Findling, Robert L.;  Chang, Kiki;  DelBello, Melissa P.;  Kane, John M.;  Tohen, Mauricio;  Xiang, Yu-Tao;  Correll, Christoph U.
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date:2018/10/30
Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting Journal article
ANNALS OF CLINICAL PSYCHIATRY, 2017,Volume: 29,Issue: 2,Page: 92-107
Authors:  Correll, Christoph U.;  Yu, Xin;  Xiang, Yutao;  Kane, John M.;  Masand, Prakash
Favorite |  | TC[WOS]:12 TC[Scopus]:0 | Submit date:2018/10/30
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis Journal article
WORLD PSYCHIATRY, 2017,Volume: 16,Issue: 1,Page: 77-89
Authors:  Galling, Britta;  Roldan, Alexandra;  Hagi, Katsuhiko;  Rietschel, Liz;  Walyzada, Frozan;  Zheng, Wei;  Cao, Xiao-Lan;  Xiang, Yu-Tao;  Zink, Mathias;  Kane, John M.;  Nielsen, Jimmi;  Leucht, Stefan;  Correll, Christoph U.
Favorite |  | TC[WOS]:79 TC[Scopus]:86 | Submit date:2018/10/30
Antipsychotics  Polypharmacy  Augmentation  Monotherapy  Schizophrenia  Clozapine  Aripiprazole  
Efficacy of atypical antipsychotics in the management of acute agitation and aggression in hospitalized patients with schizophrenia or bipolar disorder: results from a systematic review Journal article
Shanghai Archives of Psychiatry, 2016,Volume: 28,Issue: 5,Page: 241-252
Authors:  Yu,Xin;  Correll,Christoph U.;  Xiang,Yu Tao;  Xu,Yifeng;  Huang,Jizhong;  Yang,Fude;  Wang,Gang;  Si,Tianmei;  Kane,John M.;  Masand,Prakash
Favorite |  | TC[WOS]:0 TC[Scopus]:7 | Submit date:2021/03/02
Aggression  Agitation  Antipsychotic  Bipolar disorder  Schizophrenia  
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: Results from a systematic review and meta-analysis of randomized controlled trials Journal article
Expert Opinion on Drug Safety, 2016,Volume: 15,Issue: 5,Page: 591-612
Authors:  Galling,Britta;  Roldán,Alexandra;  Rietschel,Liz;  Hagi,Katsuhiko;  Walyzada,Frozan;  Zheng,Wei;  Cao,Xiao Lan;  Xiang,Yu Tao;  Kane,John M.;  Correll,Christoph U.
Favorite |  | TC[WOS]:20 TC[Scopus]:23 | Submit date:2021/03/02
adverse effects  Antipsychotics  augmentation  combination  cotreatment  metaanalysis  monotherapy  polypharmacy  safety  schizophrenia  tolerability  
Worldwide differences in regulations of clozapine use Journal article
CNS Drugs, 2016,Volume: 30,Issue: 2,Page: 149-161
Authors:  Nielsen,Jimmi;  Young,Corina;  Ifteni,Petru;  Kishimoto,Taishiro;  Xiang,Yu Tao;  Schulte,Peter F.J.;  Correll,Christoph U.;  Taylor,David
Favorite |  | TC[WOS]:78 TC[Scopus]:76 | Submit date:2021/03/02